Professional Documents
Culture Documents
7 Aug 2013
Price Relative
RM 7.5 260 6.5 5.5 4.5 3.5 2.5 1.5 Aug-09 240 220 200 180 160 140 120 100 Aug-10 Aug-11 Aug-12 80 Aug-13 Relative Index
Share price has reached our TP. The share price has risen since our report on 10 Jun and has reached our TP. We now downgrade the stock to HOLD, but maintain our RM6.60 TP. Hartalegas fundamentals remains strong i.e. robust demand for nitrile gloves and improving efficiency and line speed will continue to drive earnings growth and sustain margins despite competition, and it remains the most profitable glovemaker in the sector with the highest margins (30% vs 12% peers average) and ROE (31% vs 17% peer average). Current valuation at 19x CY14 EPS has priced in the positives. Our TP is pegged to 18x CY14 EPS (fully diluted), similar to our valuation for Top Glove. 1QFY14 net profit was flat q-o-q. Sales volume growth remained robust at c.5% q-o-q (vs 2% in 4QFY13). Average selling prices (ASP) fell 10% q-o-q as lower raw material costs were passed on to customers. However, it booked RM6m net forex losses and change in fair value of forward exchange contracts in 1QFY14. Despite this, operating margin was stable at 30%. Upside risk to forecast earnings is sustainable USD strength. We expect moderate earnings growth in FY14, before accelerating to 16% in FY15 as Hartalega commissions its new capacities at NGC. Hartalega should benefit from lower raw material prices and stronger USD/RM in the short term, before they are passed on to customers
At A Glance Issued Capital (m shrs) Mkt. Cap (RMm/US$m) Major Shareholders Hartalega Industries (%) EPF (%) Free Float (%) Avg. Daily Vol.(000) 739 5,024 / 1,555 50.5 6.1 49.5 792
Revenue EBITDA Pre-tax Profit Net Profit Net Pft (Pre Ex.) EPS (sen) EPS Pre Ex. (sen) EPS Gth (%) EPS Gth Pre Ex (%) Diluted EPS (sen) Net DPS (sen) BV Per Share (sen) PE (X) PE Pre Ex. (X) P/Cash Flow (X) EV/EBITDA (X) Net Div Yield (%) P/Book Value (X) Net Debt/Equity (X) ROAE (%) Earnings Rev (%): Consensus EPS (sen sen): sen : Other Broker Recs:
1,032 336 306 235 235 32.3 32.3 11 11 32.3 14.5 105.3 21.1 21.1 15.6 14.2 2.1 6.5 CASH 33.9
1,248 377 340 262 262 32.6 32.6 1 1 32.6 14.7 113.5 20.8 20.8 15.8 13.9 2.2 6.0 CASH 31.2 na 34.8 B: 7
1,471 450 398 302 302 37.7 37.7 16 16 37.7 17.0 134.3 18.0 18.0 15.4 11.6 2.5 5.1 CASH 30.5 na 38.1 S: 3
1,700 520 453 344 344 42.9 42.9 14 14 42.9 19.3 157.9 15.8 15.8 13.5 9.9 2.8 4.3 CASH 29.4 na 43.7 H: 9
ICB Industry : Health Care ICB Sector: Health Care Equipment & Services Principal Business: Latex examination gloves, nitrile gloves and technical rubber products manufacturer
In Singapore, this research report or research analyses may only be distributed to Institutional Investors, Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore. www.dbsvickers.com ed: SGC / sa: WMT
Recipients of this report, received from DBS Vickers Research (Singapore) Pte Ltd (DBSVR), are to contact DBSVR at +65 6398 7954 in respect of any matters arising from or in connection with this report.
40%
31%
32%
32%
30%
30%
28%
28%
30%
35%
27%
30%
35%
27% 27%
27%
27%
30%
22% 20%
26%
25%
15%
17%
FY14F
FY15F
4Q08
1Q09
2Q09
3Q09
4Q09
1Q10
2Q10
3Q10
4Q10
1Q11
2Q11
3Q11
4Q11
1Q12
2Q12
3Q12
4Q12
1Q13
2Q13
3Q13
4Q13
1Q14
Top Glove
Supermax
Kossan
Hartalega
5.00
Jan-06 Mar-06 May-06 Jul-06 Sep-06 Nov-06 Jan-07 Mar-07 May-07 Jul-07 Sep-07 Nov-07 Jan-08 Mar-08 May-08 Jul-08 Sep-08 Nov-08 Jan-09 Mar-09 May-09 Jul-09 Sep-09 Nov-09 Jan-10 Mar-10 May-10 Jul-10 Sep-10 Nov-10 Jan-11 Mar-11 May-11 Jul-11 Sep-11 Nov-11 Jan-12 Mar-12 May-12 Jul-12 Sep-12 Nov-12 Jan-13 Mar-13 May-13 Jul-13
0.00
Aug-08
Aug-09
Aug-10
Aug-11
Aug-12
May-08
May-09
May-10
May-11
May-12
USDMYR Curncy
Peer comparison
Share Company Top Glove Supermax Kossan Rubber Hartalega Sector Average Price (RM) 6.02 2.26 6.10 6.80 Target Price Price (RM) 7.20 NA 4.50 6.60 Market Cap (US$m) 1,208 497 629 1,626 PE (x) CY12 18.1 12.6 18.7 22.0 17.8 PE (x) CY13 16.8 10.9 16.5 21.3 16.4 PE (x) CY14 15.1 9.8 14.3 19.2 14.6 P/BV (x) 2.7 1.6 1.8 5.2 2.8 Div Yield (%) 2.9 2.6 1.9 2.3 2.4 ROE (%) 16 15 18 31 20
Page 2
May-13
Aug-13
Nov-08
Nov-09
Nov-10
Nov-11
Nov-12
Feb-09
Feb-10
Feb-11
Feb-12
Feb-13
Sensitivity Analysis
2012
Capacity (bln pcs) Utilisation (%) Nitrile latex (RM/kg) NR latex (RM/kg)
Segmental Breakdown
FY Mar 2012 2012A 2013A 2013A 2014F 2014F 2015F 2015F 2016F 2016F
Revenues (RM m) North America South America Asia Europe Others Total Income Statement (RM m)
FY Mar
North America remained Hartalegas largest market (58% of total sales) but it is making inroads in Asia (10% of total sales).
2012A 2012A
2013A 2013A
2014F 2014F
2015F 2015F
2016F 2016F
Revenue Cost of Goods Sold Gross Profit Other Opng (Exp)/Inc Operating Profit Other Non Opg (Exp)/Inc Associates & JV Inc Net Interest (Exp)/Inc Exceptional Gain/(Loss) PrePre-tax Profit Tax Minority Interest Preference Dividend Net Profit Net Profit before Except. EBITDA Growth Revenue Gth (%) EBITDA Gth (%) Opg Profit Gth (%) Net Profit Gth (%) Margins & Ratio Gross Margins (%) Opg Profit Margin (%) Net Profit Margin (%) ROAE (%) ROA (%) ROCE (%) Div Payout Ratio (%) Net Interest Cover (x)
931 (673) 258 2 260 0 0 (2) 0 259 (57) 0 0 202 202 281 26.7 5.9 5.9 6.0 27.7 28.0 21.7 36.2 29.0 32.3 45.3 149.9
1,032 (731) 301 6 307 0 0 (1) 0 306 (71) 0 0 235 235 336 10.8 19.4 17.8 16.4 29.1 29.7 22.7 33.9 27.7 31.1 45.0 339.7
1,248 (913) 334 6 340 0 0 (1) 0 340 (78) 0 0 262 262 377 20.9 12.4 10.9 11.4 26.8 27.3 21.0 31.2 25.0 29.1 45.0 570.4
1,471 (1,078) 393 6 399 0 0 (1) 0 398 (96) 0 0 302 302 302 450 17.9 19.4 17.1 15.6 26.7 27.1 20.6 30.5 24.1 28.7 45.0 668.1
1,700 (1,252) 447 6 453 0 0 (1) 0 453 (109) 0 0 344 344 520 15.6 15.4 13.7 13.7 26.3 26.7 20.2 29.4 23.5 27.9 45.0 759.8
Margins Trend
31.0% 29.0% 27.0% 25.0% 23.0% 21.0% 19.0% 2012A 2013A 2014F 2015F 2016F
Operating Margin % Net Income Margin %
Competition in nitrile gloves will pressure margins, but enhanced productivity and efficiency will mitigate the impact.
Page 3
Revenue Trend
300 250 16% 14% 12% 200 150 6% 100 50 0% 0
4Q2011 1Q2012 2Q2012 3Q2012 4Q2012 1Q2013 2Q2013 3Q2013 4Q2013 1Q2014
Revenue Cost of Goods Sold Gross Profit Other Oper. (Exp)/Inc Operating Profit Other Non Opg (Exp)/Inc Associates & JV Inc Net Interest (Exp)/Inc Exceptional Gain/(Loss) PrePre-tax Profit Tax Minority Interest Net Profit Net profit bef Except. EBITDA Growth Revenue Gth (%) EBITDA Gth (%) Opg Profit Gth (%) Net Profit Gth (%) Margins Gross Margins (%) Opg Profit Margins (%) Net Profit Margins (%)
10% 8%
4% 2%
-2%
Revenue
Revenue grew 3% q-o-q despite ASP falling 10% q-oq due to strong volume growth in the quarter (+5%)
Booked RM6m forex losses and change in fair value of forward exchange contracts.
Asset Breakdown (2014) 380 0 0 163 98 108 10 758 13 30 43 12 41 620 1 758 142 139 39.6 17.8 45.5 1.3 4.4 3.2 CASH CASH 244.4 23.4 535 0 8 182 87 120 5 936 8 56 51 4 50 766 1 936 104 170 40.2 22.3 47.8 1.2 3.4 2.6 CASH CASH 1,537.4 20.3 668 0 8 225 107 145 5 1,158 8 70 116 4 50 909 1 1,158 72 213 38.8 26.2 40.4 1.2 2.5 1.9 CASH CASH 1,521.0 16.0 787 0 8 258 126 171 5 1,354 8 82 133 4 50 1,076 1 1,354 87 246 39.2 26.9 41.5 1.2 2.5 1.9 CASH CASH 1,521.0 14.7 891 0 8 323 146 198 5 1,570 8 95 146 4 50 1,265 1 1,570 107 311 39.6 27.2 41.9 1.2 2.7 2.1 CASH CASH 1,521.0 NA
Debtors 12.7% Net Fixed Assets 58.3%
Net Fixed Assets Invts in Associates & JVs Other LT Assets Cash & ST Invts Inventory Debtors Other Current Assets Total Assets ST Debt Creditor Other Current Liab LT Debt Other LT Liabilities Shareholders Equity Minority Interests Total Cap. & Liab. Non-Cash Wkg. Capital Net Cash/(Debt) Debtors Turn (avg days) Creditors Turn (avg days) Inventory Turn (avg days) Asset Turnover (x) Current Ratio (x) Quick Ratio (x) Net Debt/Equity (X) Net Debt/Equity ex MI (X) Capex to Debt (%) Z-Score (X)
Assocs'/JVs 0.0% Inventory 9.4% Bank, Cash and Liquid Assets 19.6%
Page 4
Capital Expenditure
200 180 160 140 120 100 80 60 40 20 0 2012A 2013A 2014F 2015F 2016F
Pre-Tax Profit Dep. & Amort. Tax Paid Assoc. & JV Inc/(loss) Chg in Wkg.Cap. Other Operating CF Net Operating CF Capital Exp.(net) Other Invts.(net) Invts in Assoc. & JV Div from Assoc & JV Other Investing CF Net Investing CF Div Paid Chg in Gross Debt Capital Issues Other Financing CF Net Financing CF Currency Adjustments Chg in Cash Opg CFPS (sen) Free CFPS (sen)
259 29 (49) 0 (44) 7 201 (60) 0 0 0 0 (60) (87) (15) 0 7 (95) 0 46 35.5 20.4
306 37 (59) 0 36 (2) 317 (187) 0 0 0 (7) (194) (99) (12) 0 7 (104) 0 19 38.7 17.9
340 52 (14) 0 (32) 0 345 (185) 0 0 0 0 (185) (118) 0 0 0 (118) 0 43 47.1 20.0
398 66 (78) 0 (33) 0 354 (185) 0 0 0 0 (185) (136) 0 0 0 (136) 0 33 48.2 21.1
453 81 (96) 0 (34) 0 405 (185) 0 0 0 0 (185) (155) 0 0 0 (155) 0 65 54.7 27.4
RM S.No . 1: 2: Cl o s i n g Ta rg e t Pri c e Pri c e 08 Aug 12 4.50 4.70 07 Nov 12 5.01 4.70 Da te 23 Nov 12 15 Jan 13 06 Feb 13 20 Feb 13 23 Apr 13 09 May 13 10 Jun 13 4.82 4.93 4.64 4.75 5.27 5.67 5.87 4.70 4.70 4.80 4.80 5.50 5.50 6.60 R a ti n g Hold Hold Hold Hold Hold Hold Hold Hold Buy
8
5.53
3:
9 7 2 4 6 3 5 1
4: 5: 6: 7: 8: 9:
Dec-12
Apr-13
Aug-13
Not e : Share price and Target price are adjusted for corporate actions.
Page 5
DBSV recommendations are based an Absolute Total Return* Rating system, defined as follows: STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame) BUY (>15% total return over the next 12 months for small caps, >10% for large caps) HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps) FULLY VALUED (negative total return i.e. > -10% over the next 12 months) SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
GENERAL DISCLOSURE/DISCLAIMER This report is prepared by DBS Vickers Research (Singapore) Pte Ltd ("DBSVR"), a direct wholly-owned subsidiary of DBS Vickers Securities (Singapore) Pte Ltd ("DBSVS") and an indirect wholly-owned subsidiary of DBS Vickers Securities Holdings Pte Ltd ("DBSVH"). This report is intended for clients of DBSV Group only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of DBSVR. It is being distributed in the United States by DBSV US, which accepts responsibility for its contents. Any U.S. person receiving this report who wishes to effect transactions in any securities referred to herein should contact DBS Vickers Securities (USA) Inc (DBSVUSA) directly and not its affiliate. The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBSVR, DBSVS, and/or DBSVH) do not make any representation or warranty as to its accuracy, completeness or correctness. Opinions expressed are subject to change without notice. This document is prepared for general circulation. Any recommendation contained in this document does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This document is for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate independent legal or financial advice. DBSVR accepts no liability whatsoever for any direct, indirect and/or consequential loss (including any claims for loss of profit) arising from any use of and/or reliance upon this document and/or further communication given in relation to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. DBSVH is a wholly-owned subsidiary of DBS Bank Ltd. DBS Bank Ltd along with its affiliates and/or persons associated with any of them may from time to time have interests in the securities mentioned in this document. DBSVR, DBSVS, DBS Bank Ltd and their associates, their directors, and/or employees may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking services for these companies. Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments. The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED UPON as a representation and/or warranty by DBSVR, DBSVS and/or DBSVH (and/or any persons associated with the aforesaid entities), that: (a) (b) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments stated therein.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies) mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the commodity referred to in this report. DBS Vickers Securities (USA) Inc ("DBSVUSA")"), a U.S.-registered broker-dealer, does not have its own investment banking or research department, nor has it participated in any investment banking transaction as a manager or co-manager in the past twelve months. Any US persons wishing to obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact DBSVUSA exclusively.
ANALYST CERTIFICATION CERTIFICATION The research analyst primarily responsible for the content of this research report, in part or in whole, certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report. As of 7 Aug 2013, the analyst and his / her spouse and/or relatives who are financially dependent on the analyst, do not hold interests in the securities recommended in this report (interest includes direct or indirect ownership of securities, directorships and trustee positions).
Page 6
COMPANYCOMPANY-SPECIFIC / REGULATORY DISCLOSURES DISCLOSURES DBS Vickers Securities (Singapore) Pte Ltd and its subsidiaries do not have a proprietary position in the company mentioned as 1. of 05-Aug-2013 2. DBSVR, DBSVS, DBS Bank Ltd and/or other affiliates of DBS Vickers Securities (USA) Inc ("DBSVUSA"), a U.S.-registered brokerdealer, may beneficially own a total of 1% or more of any class of common equity securities of the company mentioned as of 7 Aug 2013. Compensation for investment banking services: i. DBSVR, DBSVS, DBS Bank Ltd and/or other affiliates of DBSVUSA may have received compensation, within the past 12 months, and within the next 3 months receive or intends to seek compensation for investment banking services from the company mentioned. DBSVUSA does not have its own investment banking or research department, nor has it participated in any investment banking transaction as a manager or co-manager in the past twelve months. Any US persons wishing to obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact DBSVUSA exclusively.
3.
ii.
RESTRICTIONS ON DISTRIBUTION DISTRIBUTION General This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. Australia This report is being distributed in Australia by DBSVR and DBSVS, which are exempted from the requirement to hold an Australian financial services licence under the Corporation Act 2001 [CA] in respect of financial services provided to the recipients. DBSVR and DBSVS are regulated by the Monetary Authority of Singapore [MAS] under the laws of Singapore, which differ from Australian laws. Distribution of this report is intended only for wholesale investors within the meaning of the CA. This report is being distributed in Hong Kong by DBS Vickers (Hong Kong) Limited which is licensed and regulated by the Hong Kong Securities and Futures Commission. This report is being distributed in Singapore by DBSVR, which holds a Financial Advisers licence and is regulated by the MAS. This report may additionally be distributed in Singapore by DBSVS (Company Regn. No. 198600294G), which is an Exempt Financial Adviser as defined under the Financial Advisers Act. Any research report produced by a foreign DBS Vickers entity, analyst or affiliate is distributed in Singapore only to Institutional Investors, Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chap. 289 of Singapore. Any distribution of research reports published by a foreign-related corporation of DBSVR/DBSVS to Accredited Investors is provided pursuant to the approval by MAS of research distribution arrangements under Paragraph 11 of the First Schedule to the FAA. This report is being distributed in the UK by DBS Vickers Securities (UK) Ltd, who is an authorised person in the meaning of the Financial Services and Markets Act and is regulated by The Financial Services Authority. Research distributed in the UK is intended only for institutional clients. This report is being distributed in Dubai/United Arab Emirates by DBS Bank Ltd, Dubai (PO Box 506538, 3rd Floor, Building 3, Gate Precinct, DIFC, Dubai, United Arab Emirates) and is intended only for clients who meet the DFSA regulatory criteria to be a Professional Client. It should not be relied upon by or distributed to Retail Clients. DBS Bank Ltd, Dubai is regulated by the Dubai Financial Services Authority. Neither this report nor any copy hereof may be taken or distributed into the United States or to any U.S. person except in compliance with any applicable U.S. laws and regulations. In any other jurisdictions, except if otherwise restricted by laws or regulations, this report is intended only for qualified, professional, institutional or sophisticated investors as defined in the laws and regulations of such jurisdictions.
Hong Kong
Singapore
United Kingdom
United States
Other jurisdictions
DBS Vickers Research (Singapore) Pte Ltd 12 Marina Boulevard, Level 40, Marina Bay Financial Central Tower 3, Singapore 018982 Tel. 65-6327 2288 Company Regn. No. 198600295W
Page 7